Trials / Unknown
UnknownNCT03465631
Upper Extremity Rehabilitation Using SMART Glove System With Transcranial Direct Current Stimulation
Distal Upper Extremity Rehabilitation Using SMART Glove System With Transcranial Direct Current Stimulation (tDCS) for Stroke Patients : a Double-blinded, Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- National Rehabilitation Center, Seoul, Korea · Other Government
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study to investigate the effect of combined bilateral tDCS and VR-based therapy on distal upper extremity training in patients with stroke. We hypothesized that experimental group (VR-based training with dual-tDCS) would improve distal upper extremity function rather than control group (VR-based training with dual sham tDCS).
Detailed description
This is a double-blind, randomized controlled study. Patients were randomly assigned to 1 : 1 ratio to experimental group (VR-based training with dual-tDCS; VR-Dual) or the control group (VR-based training with dual sham tDCS; VR-Sham) . For both conditions, VR-Dual and VR-Sham group commenced at the same time (20 minutes). The therapist and patients were blinded as to whether the patients received real or sham tDCS. The study was approved by the Ethics Committee of the National Rehabilitation Center, Korea, and all participants provided written informed consent before enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SMART Glove system with tDCS | combined bilateral tDCS and VR-based therapy on distal upper extremity training in patients with stroke. |
| DEVICE | SMART Glove system with sham-tDCS | combined bilateral tDCS and VR-based therapy on distal upper extremity training in patients with stroke. |
Timeline
- Start date
- 2016-08-09
- Primary completion
- 2018-03-31
- Completion
- 2018-03-31
- First posted
- 2018-03-14
- Last updated
- 2018-03-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03465631. Inclusion in this directory is not an endorsement.